These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Depot haloperidol treatment in outpatients with schizophrenia on monotherapy: impact of CYP2D6 polymorphism on pharmacokinetics and treatment outcome. Panagiotidis G; Arthur HW; Lindh JD; Dahl ML; Sjöqvist F Ther Drug Monit; 2007 Aug; 29(4):417-22. PubMed ID: 17667795 [TBL] [Abstract][Full Text] [Related]
23. Negative correlation between alpha-1-acid-glycoprotein plasma level and response to haloperidol in the acute treatment of schizophrenia. Levinson I; Levine S Biol Psychiatry; 1995 Aug; 38(3):198-200. PubMed ID: 7578667 [No Abstract] [Full Text] [Related]
25. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial. Akhondzadeh S; Safarcherati A; Amini H Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232 [TBL] [Abstract][Full Text] [Related]
26. The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: an open-label pilot study. Sivrioglu EY; Kirli S; Sipahioglu D; Gursoy B; Sarandöl E Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1493-9. PubMed ID: 17688987 [TBL] [Abstract][Full Text] [Related]
27. Effect of varying haloperidol plasma levels on negative symptoms in schizophrenia and schizoaffective disorder. Volavka J; Cooper TB; Czobor P; Meisner M Psychopharmacol Bull; 1996; 32(1):75-9. PubMed ID: 8927679 [TBL] [Abstract][Full Text] [Related]
28. Dose and blood levels of haloperidol in treatment of mania. Rifkin A; Karajgi B; Doddi S; Cooper T Psychopharmacol Bull; 1990; 26(1):144-6. PubMed ID: 2371369 [TBL] [Abstract][Full Text] [Related]
29. Haloperidol and thioridazine drug levels and clinical response in schizophrenia: comparison of gas-liquid chromatography and radioreceptor drug level assays. Smith RC; Baumgartner R; Burd A; Ravichandran GK; Mauldin M Psychopharmacol Bull; 1985; 21(1):52-8. PubMed ID: 3983338 [No Abstract] [Full Text] [Related]
30. Comparative efficacy of red cell and plasma haloperidol as predictors of clinical response in schizophrenia. Smith RC; Baumgartner R; Shvartsburd A; Ravichandran GK; Vroulis G; Mauldin M Psychopharmacology (Berl); 1985; 85(4):449-55. PubMed ID: 2862652 [TBL] [Abstract][Full Text] [Related]
31. Haloperidol and reduced haloperidol in saliva and blood. Dysken MW; Johnson SB; Holden L; Kuskowski M; Ofstehage J; Skare S; Vatassery G J Clin Psychopharmacol; 1992 Jun; 12(3):186-90. PubMed ID: 1629385 [TBL] [Abstract][Full Text] [Related]
33. Correlation of haloperidol levels between saliva and plasma of acutely ill schizophrenic patients. Jain T; Bhandari A; Ram V; Sharma S; Parakh M; Parakh MC Clin Biochem; 2011 Jun; 44(8-9):675-80. PubMed ID: 21458435 [TBL] [Abstract][Full Text] [Related]
34. [Comparison of the therapeutic effects between haloperidol and insulin coma in schizophrenia and optimal blood levels of haloperidol]. Shu L Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Feb; 20(1):43-8. PubMed ID: 3304870 [No Abstract] [Full Text] [Related]
35. Does a therapeutic window for plasma haloperidol exist?: Preliminary Chinese data. Potkin SG; Shen YC; Zhou DF; Pardes H; Shu L; Phelps B; Poland R Psychopharmacol Bull; 1985; 21(1):59-61. PubMed ID: 3983339 [No Abstract] [Full Text] [Related]